FRABOC: Breast Cancer Family History Risk Tool Australia

A breast cancer diagnosis in your family changes how you think about your own health. That quiet worry grows when you have no clear answers about your personal risk. FRABOC gave Australian doctors a structured, evidence-based method to assess familial breast and ovarian cancer risk so women could stop guessing and start planning.

What Is FRABOC and Who Created It?

FRABOC stands for Familial Risk Assessment – Breast and Ovarian Cancer. Cancer Australia developed this clinical tool specifically for general practitioners and nurses working in primary care settings across the country.

The purpose was straightforward. A GP could sit down with a patient, map out her family cancer history, and use FRABOC to place her into a clear risk category. This moved the conversation past vague reassurance and into actionable territory.

Cancer Australia built the tool on peer-reviewed epidemiological data and aligned it with national clinical guidelines for familial breast cancer. It was never a public-facing quiz you would fill out on your phone at midnight. It was a clinical instrument designed for trained health professionals.

How Did FRABOC Assess Breast Cancer Risk?

The FRABOC assessment centred on detailed family history collection. Your doctor would ask about first-degree and second-degree relatives on both your maternal and paternal sides.

Key data points included the number of relatives diagnosed with breast or ovarian cancer, the ages at which they received their diagnoses, and whether any known BRCA1 or BRCA2 gene mutations existed in the family. Male relatives with breast cancer also triggered specific risk flags within the tool.

This structured approach removed guesswork. Instead of a GP relying on memory or general knowledge, FRABOC provided a standardised framework that produced consistent results regardless of which clinic you visited.

What Are the Three FRABOC Risk Categories?

FRABOC sorted women into three distinct risk levels. Understanding these categories helps you make sense of what a family history assessment actually tells you.

At or slightly above average risk covers more than 95% of Australian women. This group includes those with no family history and those with one or two affected relatives whose diagnoses do not suggest a hereditary pattern. Standard BreastScreen Australia mammogram schedules apply here.

Moderately increased risk applies to women whose family history shows a more notable clustering of diagnoses. Your GP may recommend starting mammograms earlier or screening more frequently than the standard two-year interval.

Potentially high risk describes women whose family patterns strongly suggest an inherited cancer syndrome. This category triggers a referral to a Family Cancer Clinic for specialist evaluation and possible genetic testing.

Does Family History Guarantee Breast Cancer?

No. This is the single most important fact to absorb. Breast cancer affects roughly one in seven Australian women over a lifetime, which means many families will see a diagnosis simply because the disease is common.

One older relative diagnosed after age 60 may not shift your personal risk in any meaningful way. FRABOC accounted for this reality by weighing the pattern of diagnoses rather than the mere presence of them.

A family history raises concern when specific signals cluster together. The tool was designed to separate background noise from genuine hereditary risk, giving you and your doctor a clearer picture to work with.

Which Family Patterns Raise Your Risk the Most?

Several specific patterns carry more weight than others in familial risk assessment. These are the signals that tools like FRABOC were built to identify.

• Two or more close relatives on the same side of the family diagnosed with breast cancer
• Any relative diagnosed with breast cancer before age 50
• A combination of breast and ovarian cancer within the same family line
• A male relative diagnosed with breast cancer at any age
• A confirmed BRCA1 or BRCA2 gene mutation already identified through genetic testing
• A relative with bilateral breast cancer (cancer in both breasts)

Each of these factors individually increases concern. When several appear together in one family tree, the case for specialist referral becomes much stronger.

Why Does Your Father’s Side Matter Too?

Many women focus exclusively on their mother’s family when thinking about breast cancer risk. This is a common and understandable mistake.

BRCA1 and BRCA2 gene mutations pass through either parent with equal probability. Your father can carry a mutation without ever developing cancer himself and still transmit it to you. A paternal aunt or grandmother with breast cancer carries the same genetic significance as a maternal one.

FRABOC required GPs to collect history from both parental lines for exactly this reason. A complete family history that ignores your father’s side leaves a significant blind spot in your risk assessment.

What Replaced FRABOC in Australia?

Cancer Australia transitioned from FRABOC to a newer tool called iPrevent, developed by researchers at the Peter MacCallum Cancer Centre in Melbourne. The shift reflects how much breast cancer risk science has advanced since the original tool launched.

iPrevent goes beyond family history alone. It incorporates breast density measurements, reproductive history, hormone replacement therapy use, body mass index, and alcohol consumption alongside your family cancer data. The result is a personalised five-year and lifetime risk estimate rather than a broad categorical placement.

This represents a meaningful upgrade in precision. Where FRABOC gave you a category, iPrevent gives you a number tailored to your specific combination of risk factors.

How Does iPrevent Compare to FRABOC?

The core mission remains the same. Both tools exist to help Australian health professionals translate complex risk data into clear, actionable guidance for their patients.

The differences lie in scope and output. FRABOC relied primarily on family history and produced a three-tier risk category. iPrevent layers in personal health and lifestyle variables and generates individualised percentage-based risk estimates.

Neither tool replaces clinical judgement. Both function as decision-support instruments that help your GP determine whether standard screening is sufficient or whether you need specialist attention. The conversation between you and your doctor remains the most important part of the process.

When Should You Visit a Family Cancer Clinic?

A referral to a Family Cancer Clinic typically follows a high-risk assessment outcome. These specialised clinics operate within major Australian hospitals and cancer centres.

You should consider asking your GP about a referral if your family history includes multiple relatives with breast or ovarian cancer, especially if diagnoses occurred at young ages. A known BRCA mutation in your family is another clear trigger for specialist evaluation.

At the clinic, a genetic counsellor will take a comprehensive family history, discuss the implications of genetic testing, and help you understand your options. Testing itself is a personal decision, and the counselling process ensures you make it with full information and support.

What Happens During a Genetic Risk Assessment?

A genetic risk assessment begins with a detailed conversation about your family medical history across at least three generations. The clinician will ask about cancer types, ages at diagnosis, and any previous genetic test results in the family.

If your history suggests a possible hereditary syndrome, the clinician may recommend a blood or saliva test to check for mutations in genes like BRCA1, BRCA2, PALB2, and others linked to breast and ovarian cancer. Results typically take several weeks.

A positive result does not mean you will develop cancer. It means your lifetime risk is higher than average, and your medical team can build a personalised surveillance and prevention plan around that knowledge. A negative result in a family with a known mutation can be equally powerful, providing genuine reassurance.

How Often Should You Screen Based on Your Risk Level?

Screening frequency depends directly on your assessed risk category. Australian guidelines align closely with the framework that FRABOC originally supported.

• Average risk: Mammogram through BreastScreen Australia every two years starting at age 50 (free for women aged 40 and over)
• Moderately increased risk: Annual mammograms starting at an age determined by your GP, often 10 years before the youngest family diagnosis
• High risk: Annual mammograms and possibly breast MRI starting as early as age 25 to 30, coordinated through a Family Cancer Clinic

Your screening schedule should evolve as new family information emerges. A new diagnosis in a close relative may shift your risk category and change your recommended screening plan.

What Should You Tell Your GP About Family History?

Come prepared with as much detail as you can gather before your appointment. The quality of your risk assessment depends heavily on the accuracy of the information you provide.

Write down the names and relationships of any family members who have had cancer, the type of cancer each person was diagnosed with, and their approximate age at diagnosis. Include both your mother’s and father’s sides. If anyone in the family has had genetic testing, bring those results if you can access them.

Your GP will use this information within a risk assessment framework to determine your category and next steps. Even if your family history turns out to place you in the average risk group, the peace of mind that comes from a proper assessment is worth the appointment.

Frequently Asked Questions

Is FRABOC still available in Australia?

No. Cancer Australia has retired FRABOC and replaced it with iPrevent, a more comprehensive risk assessment tool developed by the Peter MacCallum Cancer Centre. Your GP can access iPrevent during your consultation.

What does FRABOC stand for?

FRABOC stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was a clinical decision-support tool that helped Australian GPs categorise a patient’s hereditary breast and ovarian cancer risk based on family history.

Can FRABOC predict if I will get breast cancer?

No risk assessment tool can predict individual outcomes. FRABOC estimated your risk category relative to the general population based on family patterns. It identified probability, not certainty.

Do I need a referral to use iPrevent?

iPrevent is a clinical tool designed for use by health professionals during consultations. You do not access it directly yourself. Book an appointment with your GP and ask for a familial breast cancer risk assessment.

What is considered a strong family history of breast cancer?

A strong family history typically includes multiple close relatives on the same side of the family with breast or ovarian cancer, diagnoses before age 50, male breast cancer, or a known BRCA gene mutation. These patterns suggest possible hereditary risk.

How accurate are familial risk assessment tools?

Tools like FRABOC and iPrevent are built on large-scale epidemiological data and validated against population outcomes. They provide reliable risk estimates for clinical decision-making, though no tool captures every individual variable that may influence cancer development.

Take the Next Step Today

FRABOC showed Australia that structured, evidence-based family history assessment belongs in every GP consultation about breast cancer risk. The tool has evolved into iPrevent, but the principle remains unchanged: your family history is medical information that deserves proper evaluation.

If a cancer diagnosis in your family has left you with unanswered questions, book an appointment with your GP this month. Bring your family history notes. Ask for a formal risk assessment. The conversation takes less time than you think, and the clarity it provides can quiet the worry you have been carrying alone.

Your health decisions deserve real data, not guesswork. Start the conversation.